Although elevated HO-1 activity reduces OS and protects tissues from oxidative insult, in this case, cardiac ISA/REP-induced injury along with HD-BC treatment markedly activated HO-1, which could result in the increased release of Fe2+ from heme as a consequence of the HO-1 activity. The gene discussed is HMOX1; the disease is breast cancer.